CompaniesNeXstar Pharmaceutical

NeXstar Pharmaceutical

defunct

About

Defunct Company

Areas of Focus

Categories

MergedBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (3)

Total Trials

3

As Lead Sponsor

1

As Collaborator

2

Total Enrollment

357

By Phase

PHASE2/PHASE3: 1PHASE1: 1PHASE3: 1

By Status

COMPLETED: 3

Clinical Trials Pipeline2 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

1998

1999

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

Today

Hover over trial bars to see details

Recent Trials

NCT00263315Collaborator

Inhalation of Liposomal Amphotericin B to Prevent Invasive Aspergillosis

PHASE2/PHASE3Completed

320 participants

Started: Jan 31, 2000 · Completed: May 31, 2006

NCT00003891Collaborator

Lurtotecan Liposome in Treating Patients With Advanced Solid Tumors

PHASE1Completed

37 participants

Started: Feb 25, 1999 · Completed: Sep 22, 2008

NCT00002093Lead Sponsor

A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma.

PHASE3Completed

Funding History (11)

DEFM14A

Jun 25, 1999

8-K

Mar 9, 1999

8-K

Aug 28, 1998

8-K

Aug 19, 1998

8-K

May 29, 1998

DEF 14A

Apr 16, 1998

8-K

Aug 12, 1997

8-K

Jul 29, 1997

DEF 14A

Apr 28, 1997

8-K

Jul 8, 1996